Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 29

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylation

Gogna, Rajan, Madan, Esha, Khan, Mahmood, Pati, Uttam, Kuppusamy, Periannan · 2013 · EMBO Molecular Medicine

Abstract

Myocardial infarction, an irreversible cardiac tissue damage, involves progressive loss of cardiomyocytes due to p53‐mediated apoptosis. Oxygenation is known to promote cardiac survival through activation of NOS3 gene. We hypothesized a dual role for p53, which, depending on oxygenation, can elicit apoptotic death signals or NOS3‐mediated survival signals in the infarct heart. p53 exhibited a differential DNA‐binding, namely, BAX‐p53RE in the infarct heart or NOS3‐p53RE in the oxygenated heart, which was regulated by oxygen‐induced, post‐translational modification of p53. In the infarct heart, p53 was heavily acetylated at Lys 118 residue, which was exclusively reversed in the oxygenated heart, apparently regulated by oxygen‐dependent expression of TIP60. The inhibition of Lys 118 acetylation promoted the generation of NOS3‐promoting prosurvival form of p53. Thus, oxygenation switches p53‐DNA interaction by regulating p53 core‐domain acetylation, promoting a prosurvival transcription activity of p53. Understanding this novel oxygen‐p53 survival pathway will open new avenues in cardioprotection molecular therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201202055

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 73

  1. Alvarado‐Vasquez N, Zapata E, Alcazar‐Leyva S, Masso F, Montano LF (2007) Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes. Diabetes Metab Res Rev 23: 559-566 · DOI
  2. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243-1254 · DOI · Paper page
  3. Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D (2007) Oxygen therapy in myocardial infarction: an historical perspective. J R Soc Med 100: 130-133 · DOI
  4. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH (2006) TIGAR, a p53‐inducible regulator of glycolysis and apoptosis. Cell 126: 107-120 · DOI · Paper page
  5. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, Kitsis RN (1997) Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372 · DOI · Paper page
  6. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, et al (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378: 1847-1857 · DOI · Paper page
  7. Braithwaite AW, Del Sal G, Lu X (2006) Some p53‐binding proteins that can function as arbiters of life and death. Cell Death Differ 13: 984-993 · DOI
  8. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171 · DOI · Paper page
  9. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, et al (2002) Identification of a novel stress‐responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031 · DOI · Paper page
  10. Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, Nilakantan V, Kindwall E, Niezgoda JA, Baker JE (2006) Hyperoxic and hyperbaric‐induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 72: 143-151 · DOI
  11. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942 · DOI · Paper page
  12. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD (1999) Phosphorylation of Ser‐20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 96: 13777-13782 · DOI · Paper page
  13. Chen YK, Hsue SS, Lin LM (2003) Correlation between inducible nitric oxide synthase and p53 expression for DMBA‐induced hamster buccal‐pouch carcinomas. Oral Dis 9: 227-234 · DOI
  14. Chou AH, Lin AC, Hong KY, Hu SH, Chen YL, Chen JY, Wang HL (2011) p53 activation mediates polyglutamine‐expanded ataxin‐3 upregulation of Bax expression in cerebellar and pontine nuclei neurons. Neurochem Int 58: 145-152 · DOI
  15. Crow MT, Mani K, Nam YJ, Kitsis RN (2004) The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957-970 · DOI · Paper page
  16. Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, Phang JM (2001) Proline oxidase, encoded by p53‐induced gene‐6, catalyzes the generation of proline‐dependent reactive oxygen species. Cancer Res 61: 1810-1815
  17. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92 · DOI · Paper page
  18. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevendans PA (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61: 414-426 · DOI · Paper page
  19. Fang L, Li G, Liu G, Lee SW, Aaronson SA (2001) p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 20: 1931-1939 · DOI
  20. Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN, Ronai Z (1998) JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12: 2658-2663 · DOI · Paper page
  21. Gogna R, Madan E, Keppler B, Pati U (2012a) Gallium compound GaQ(3)‐induced Ca(2 +) signalling triggers p53‐dependent and ‐independent apoptosis in cancer cells. Br J Pharmacol 166: 617-636 · DOI
  22. Gogna R, Madan E, Kuppusamy P, Pati U (2012b) Chaperoning of mutant p53 protein by wild‐type p53 protein causes hypoxic tumor regression. J Biol Chem 287: 2907-2914 · DOI
  23. Gogna R, Madan E, Kuppusamy P, Pati U (2012c) Reactive oxygen species‐mediated p53 core‐domain modifications determine apoptotic or necrotic death in cancer cells. Antioxid Redox Signal 16: 400-412 · DOI
  24. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628 · DOI · Paper page
  25. Gu W, Roeder RG (1997) Activation of p53 sequence‐specific DNA binding by acetylation of the p53 C‐terminal domain. Cell 90: 595-606 · DOI · Paper page
  26. Hainaut P, Milner J (1993) Redox modulation of p53 conformation and sequence‐specific DNA binding in vitro. Cancer Res 53: 4469-4473
  27. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW (2002) P53‐mediated induction of Cox‐2 counteracts p53‐ or genotoxic stress‐induced apoptosis. EMBO J 21: 5635-5644 · DOI · Paper page
  28. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, et al (2004) p53‐induced up‐regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64: 2350-2356 · DOI · Paper page
  29. Janicke RU, Sohn D, Schulze‐Osthoff K (2008) The dark side of a tumor suppressor: anti‐apoptotic p53. Cell Death Differ 15: 959-976 · DOI · Paper page
  30. Kaeser MD, Iggo RD (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 99: 95-100 · DOI · Paper page
  31. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107
  32. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, et al (2008) Determination of the class and isoform selectivity of small‐molecule histone deacetylase inhibitors. Biochem J 409: 581-589 · DOI · Paper page
  33. Khan M, Meduru S, Mohan IK, Kuppusamy ML, Wisel S, Kulkarni A, Rivera BK, Hamlin RL, Kuppusamy P (2009) Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol 47: 275-287 · DOI
  34. Khan M, Meduru S, Gogna R, Madan E, Citro L, Kuppusamy ML, Sayyid M, Mostafa M, Hamlin RL, Kuppusamy P (2012) Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function. Cardiovasc Res 93: 89-99 · DOI
  35. Kim MY, Trudel LJ, Wogan GN (2009) Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res 29: 3733-3740
  36. Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H (2003) Impaired function of p53R2 in Rrm2b‐null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet 34: 440-445 · DOI
  37. Ko LJ, Prives C (1996) p53: puzzle and paradigm. Genes Dev 10: 1054-1072 · DOI · Paper page
  38. Kones R (2011) Oxygen therapy for acute myocardial infarction‐then and now. A century of uncertainty. Am J Med 124: 1000-1005 · DOI
  39. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303 · DOI · Paper page
  40. Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473: 326-335 · DOI · Paper page
  41. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilk K, Murray CM, Critchlow SE, Roux D, Simon MP, Pouyssegur J (2011) CD147 subunit of lactate/H+ symporters MCT1 and hypoxia‐inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci USA 108: 16663-16668 · DOI · Paper page
  42. Lee SJ, Kim DC, Choi BH, Ha H, Kim KT (2006) Regulation of p53 by activated protein kinase C‐delta during nitric oxide‐induced dopaminergic cell death. J Biol Chem 281: 2215-2224 · DOI
  43. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S (2003) Pirh2, a p53‐induced ubiquitin‐protein ligase, promotes p53 degradation. Cell 112: 779-791 · DOI · Paper page
  44. Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036 · DOI · Paper page
  45. Liang SH, Clarke MF (2001) Regulation of p53 localization. Eur J Biochem 268: 2779-2783 · DOI · Paper page
  46. Lu X (2010) Tied up in loops: positive and negative autoregulation of p53. Cold Spring Harb Perspect Biol 2: a000984
  47. Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi AA (2011) Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget 2: 948-957 · DOI
  48. Madan E, Gogna R, Kuppusamy P, Bhatt M, Pati U, Mahdi AA (2012) TIGAR induces p53‐mediated cell‐cycle arrest by regulation of RB–E2F1 complex. Br J Cancer 107: 516-526 · DOI
  49. Masutani H, Ueda S, Yodoi J (2005) The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 12: 991-998 · DOI
  50. Mellert H, Sykes SM, Murphy ME, McMahon SB (2007) The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6: 1304-1306 · DOI
  51. Monte M, Benetti R, Buscemi G, Sandy P, Del Sal G, Schneider C (2003) The cell cycle‐regulated protein human GTSE‐1 controls DNA damage‐induced apoptosis by affecting p53 function. J Biol Chem 278: 30356-30364 · DOI
  52. Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JP (2012) Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 165: 410-422 · DOI
  53. Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, Lee SW (2003) p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 22: 1289-1301 · DOI · Paper page
  54. Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J (2006) Intramyocardial injection of vascular endothelial growth factor‐A165 plasmid followed by granulocyte‐colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J 27: 1785-1792 · DOI
  55. Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context‐dependent oncogene. Nat Cell Biol 7: 1074-1082 · DOI · Paper page
  56. Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 132: 985-993 · DOI · Paper page
  57. Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y (1999) Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061-12066 · DOI · Paper page
  58. Tang Y, Luo J, Zhang W, Gu W (2006) Tip60‐dependent acetylation of p53 modulates the decision between cell‐cycle arrest and apoptosis. Mol Cell 24: 827-839 · DOI · Paper page
  59. Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C (1998) A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression. EMBO J 17: 5015-5025 · DOI
  60. Velasco‐Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B, Kley N (1999) PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18: 127-137 · DOI · Paper page
  61. Vousden KH (2006) Outcomes of p53 activation—spoilt for choice. J Cell Sci 119: 5015-5020 · DOI · Paper page
  62. Wieczorek AM, Waterman JL, Waterman MJ, Halazonetis TD (1996) Structure‐based rescue of common tumor‐derived p53 mutants. Nat Med 2: 1143-1146 · DOI
  63. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R (2009) Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 95: 198-202 · DOI · Paper page
  64. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, Look AT (2005) Slug antagonizes p53‐mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123: 641-653 · DOI · Paper page
  65. Xu JM, Tan R, Hu DX (2003) Effect of ischemic preconditioning on myocardial bcl‐2, bax, p53 gene expression during ischemia/reperfusion period in rabbits. Hunan Yi Ke Da Xue Xue Bao 28: 111-113
  66. Yan W, Chen X (2006) GPX2, a direct target of p63, inhibits oxidative stress‐induced apoptosis in a p53‐dependent manner. J Biol Chem 281: 7856-7862 · DOI · Paper page
  67. Yang XJ, Seto E (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 9: 206-218 · DOI · Paper page
  68. Yaoita H, Ogawa K, Maehara K, Maruyama Y (2000) Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45: 630-641 · DOI · Paper page
  69. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S (2008) Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide? J Surg Res 149: 155-164 · DOI
  70. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S (2010) Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med 11: 8-19 · DOI
  71. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW (2000) The gut‐enriched Kruppel‐like factor (Kruppel‐like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398 · DOI · Paper page
  72. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten‐Johansen J (2000) Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45: 651-660 · DOI · Paper page
  73. Zheng J, Fang J, Yin YJ, Wang XC, Ren AJ, Bai J, Sun XJ, Yuan WJ, Lin L (2010) Leptin protects cardiomyocytes from serum‐deprivation‐induced apoptosis by increasing anti‐oxidant defence. Clin Exp Pharmacol Physiol 37: 955-962 · DOI

Cited by

Metadata

Authors
Gogna, R., Madan, E., Khan, M., Pati, U., & Kuppusamy, P.
Venue
EMBO Molecular Medicine
Published
2013-10-01
Volume
5
Issue
11
Pages
1662-1683
ISSN
  • 1757-4676
  • 1757-4684
Cited by
29
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.